VectivBio is formerly owned by Sofinnova Partners, through Sofinnova Capital VIII, since 2017.

When did Sofinnova Partners acquire VectivBio?

Sofinnova Partners acquired VectivBio in 2017 and exited after 5 years.

Has VectivBio been sold?

Yes. VectivBio was exited in 2022.

Home/Companies/Biotech/VectivBio

VectivBio

Biotech·

Switzerland·Exited 2022·Held 5yr

VectivBio is a healthcare / biotech company, headquartered in Switzerland.

Entry

2017

Hold

5yr

Exit

2022

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQSwitzerland

SectorHealthcare / Biotech

GI rare disease biotech. Acquired by Ironwood Pharma for $1B in 2022

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

Corvidia Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings